Company Profile

Avails Medical Inc
Profile last edited on: 3/30/21      CAGE: 73GU3      UEI: HLMPAGQWHTL1

Business Identifier: Digital technology to provide accurate, rapid detection of infections in any bodily fluid
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1455 Adams Drive
Menlo Park, CA 94025
   (650) 427-0460
Location: Single
Congr. District: 18
County: San Mateo

Public Profile

Established by a team of Stanford alumni, Avails Medical, Inc is structured around fighting the major global health threat of antibiotic resistance. The developed technology platform directly adddresses the need radically to reduce the time required to obtain the reliable antibiotic susceptibility data that enables accurate therapy decisions. Avails' electronic biosensor technology is designed to improve accuracy in pathogen quantification and susceptibility testing directly from human specimens by eliminating crude, time-consuming culturing steps. The firm's digital technology is designed to provide accurate, rapid detection of infections in any bodily fluid while also indicating - in real-time - which drugs are most effective at the point-of-prescription. For decades, lab technicians have detected infections primarily through crude, time-consuming, error-ridden techniques of dipsticks and specimen sampling, leaving physicians to guess which antibiotic might be effective since reliable results can take days to develop. Avails' electronic biosensor technology improves accuracy in detecting infections and provides critical, timely information regarding antibiotic sensitivity and resistance. Avails' cost-effective platform will transform the diagnostics market by enabling for the first time diagnostic-guided therapy at the point-of-care, reducing time-to-treatment from days to minutes.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Oren Knopfmacher -- Co-founder and CEO

  Oren Knopfmacher -- Co-Founder & CEO

  Robert Fisher -- Co-Founder, Chief Medical Advisor

  Meike S Herget -- Co-founder and CTO

  Nancy Isaac -- Co-Founder Head of Regulatory Affairs

  Naama Stouber -- Co-Founder

Company News

There are no news available.